---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-25-001341"
form_type: "8-K"
ticker: "CTSO"
cik: "0001175151"
company_name: "Cytosorbents Corp"
filed_at: "2025-01-06T23:59:59+00:00"
generated_at: "2026-05-28T09:53:47.715124+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# CytoSorbents opens regional sales subsidiary in Dubai, UAE

## Summary
- New subsidiary in Dubai Science Park will serve as a sales hub for the Middle East and Africa.
- Dr. Phillip Chan cites growing regional demand for critical care and cardiac surgery therapies.
- Subsidiary aims to strengthen existing partnerships, support customers, and drive sales growth.
- Dubai was chosen for its strategic location, strong economy, favorable tax policies, and advanced healthcare infrastructure.

## SEC filing metadata
- accession: 0001104659-25-001341
- form_type: 8-K
- ticker: CTSO
- cik: 0001175151
- company_name: Cytosorbents Corp
- filed_at: 2025-01-06T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1175151/000110465925001341/0001104659-25-001341-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1175151/000110465925001341/tm252036d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-25-001341
- JSON: https://secwatch.observer/filing/0001104659-25-001341.json
- Plain text: https://secwatch.observer/filing/0001104659-25-001341.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.